Laparoscopic Sleeve Gastrectomy is Safe and Effective in Elderly Patients: A Comparative Analysis

Michael A. Burchett, Daniel T. McKenna, Don Selzer, Jennifer Choi, Samer G. Mattar

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Laparoscopic sleeve gastrectomy (SG) is gaining widespread popularity as a definitive bariatric operation that provides satisfactory and durable weight loss as well as comorbidity resolution. Although SG is being increasingly offered to patients of all ages, there is a paucity of reported outcomes in patients ≥62 years of age. The purpose of this study was to perform a comparative analysis of the outcomes of SG in patients >62 years versus a younger age group, with an emphasis on safety and efficacy.Methods: A retrospective analysis was performed from a prospectively collected database on patients who underwent SG from 2007 to 2012. All patients who were ≥62 years old were compared to those <62 years.Results: There were 182 patients who underwent SG, 17 of whom were ≥62 years old. There were no significant differences in demographics or comorbidity characteristics between the groups. The mean follow-up was 1 year. There was no 30-day mortality in either group. The percent excess weight loss for the younger age group was 44 ± 21 % and the older group was 44 ± 25 %. The percent total body weight loss was 22 ± 10 and 21 ± 10 %, respectively. Weight loss outcomes were maintained for up to 3 years. Comorbidity resolution and improvement rates were equivalent in both groups.Conclusions: SG is safe and effective in patients ≥62 years. Weight loss and the beneficial effects on comorbidities are equivalent among elderly and younger patients. SG should be offered to elderly patients who are deemed to be appropriate candidates.

Original languageEnglish
Pages (from-to)222-228
Number of pages7
JournalObesity Surgery
Volume25
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Gastrectomy
Weight Loss
Comorbidity
Age Groups
Bariatrics
Body Weight
Demography
Databases
Safety
Mortality

Keywords

  • Bariatric surgery
  • Elderly
  • Morbid obese
  • Sleeve gastrectomy

ASJC Scopus subject areas

  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics
  • Medicine(all)

Cite this

Laparoscopic Sleeve Gastrectomy is Safe and Effective in Elderly Patients : A Comparative Analysis. / Burchett, Michael A.; McKenna, Daniel T.; Selzer, Don; Choi, Jennifer; Mattar, Samer G.

In: Obesity Surgery, Vol. 25, No. 2, 2014, p. 222-228.

Research output: Contribution to journalArticle

Burchett, Michael A. ; McKenna, Daniel T. ; Selzer, Don ; Choi, Jennifer ; Mattar, Samer G. / Laparoscopic Sleeve Gastrectomy is Safe and Effective in Elderly Patients : A Comparative Analysis. In: Obesity Surgery. 2014 ; Vol. 25, No. 2. pp. 222-228.
@article{02eb62677a554f7eae1d3aaf42372a45,
title = "Laparoscopic Sleeve Gastrectomy is Safe and Effective in Elderly Patients: A Comparative Analysis",
abstract = "Background: Laparoscopic sleeve gastrectomy (SG) is gaining widespread popularity as a definitive bariatric operation that provides satisfactory and durable weight loss as well as comorbidity resolution. Although SG is being increasingly offered to patients of all ages, there is a paucity of reported outcomes in patients ≥62 years of age. The purpose of this study was to perform a comparative analysis of the outcomes of SG in patients >62 years versus a younger age group, with an emphasis on safety and efficacy.Methods: A retrospective analysis was performed from a prospectively collected database on patients who underwent SG from 2007 to 2012. All patients who were ≥62 years old were compared to those <62 years.Results: There were 182 patients who underwent SG, 17 of whom were ≥62 years old. There were no significant differences in demographics or comorbidity characteristics between the groups. The mean follow-up was 1 year. There was no 30-day mortality in either group. The percent excess weight loss for the younger age group was 44 ± 21 {\%} and the older group was 44 ± 25 {\%}. The percent total body weight loss was 22 ± 10 and 21 ± 10 {\%}, respectively. Weight loss outcomes were maintained for up to 3 years. Comorbidity resolution and improvement rates were equivalent in both groups.Conclusions: SG is safe and effective in patients ≥62 years. Weight loss and the beneficial effects on comorbidities are equivalent among elderly and younger patients. SG should be offered to elderly patients who are deemed to be appropriate candidates.",
keywords = "Bariatric surgery, Elderly, Morbid obese, Sleeve gastrectomy",
author = "Burchett, {Michael A.} and McKenna, {Daniel T.} and Don Selzer and Jennifer Choi and Mattar, {Samer G.}",
year = "2014",
doi = "10.1007/s11695-014-1421-9",
language = "English",
volume = "25",
pages = "222--228",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Laparoscopic Sleeve Gastrectomy is Safe and Effective in Elderly Patients

T2 - A Comparative Analysis

AU - Burchett, Michael A.

AU - McKenna, Daniel T.

AU - Selzer, Don

AU - Choi, Jennifer

AU - Mattar, Samer G.

PY - 2014

Y1 - 2014

N2 - Background: Laparoscopic sleeve gastrectomy (SG) is gaining widespread popularity as a definitive bariatric operation that provides satisfactory and durable weight loss as well as comorbidity resolution. Although SG is being increasingly offered to patients of all ages, there is a paucity of reported outcomes in patients ≥62 years of age. The purpose of this study was to perform a comparative analysis of the outcomes of SG in patients >62 years versus a younger age group, with an emphasis on safety and efficacy.Methods: A retrospective analysis was performed from a prospectively collected database on patients who underwent SG from 2007 to 2012. All patients who were ≥62 years old were compared to those <62 years.Results: There were 182 patients who underwent SG, 17 of whom were ≥62 years old. There were no significant differences in demographics or comorbidity characteristics between the groups. The mean follow-up was 1 year. There was no 30-day mortality in either group. The percent excess weight loss for the younger age group was 44 ± 21 % and the older group was 44 ± 25 %. The percent total body weight loss was 22 ± 10 and 21 ± 10 %, respectively. Weight loss outcomes were maintained for up to 3 years. Comorbidity resolution and improvement rates were equivalent in both groups.Conclusions: SG is safe and effective in patients ≥62 years. Weight loss and the beneficial effects on comorbidities are equivalent among elderly and younger patients. SG should be offered to elderly patients who are deemed to be appropriate candidates.

AB - Background: Laparoscopic sleeve gastrectomy (SG) is gaining widespread popularity as a definitive bariatric operation that provides satisfactory and durable weight loss as well as comorbidity resolution. Although SG is being increasingly offered to patients of all ages, there is a paucity of reported outcomes in patients ≥62 years of age. The purpose of this study was to perform a comparative analysis of the outcomes of SG in patients >62 years versus a younger age group, with an emphasis on safety and efficacy.Methods: A retrospective analysis was performed from a prospectively collected database on patients who underwent SG from 2007 to 2012. All patients who were ≥62 years old were compared to those <62 years.Results: There were 182 patients who underwent SG, 17 of whom were ≥62 years old. There were no significant differences in demographics or comorbidity characteristics between the groups. The mean follow-up was 1 year. There was no 30-day mortality in either group. The percent excess weight loss for the younger age group was 44 ± 21 % and the older group was 44 ± 25 %. The percent total body weight loss was 22 ± 10 and 21 ± 10 %, respectively. Weight loss outcomes were maintained for up to 3 years. Comorbidity resolution and improvement rates were equivalent in both groups.Conclusions: SG is safe and effective in patients ≥62 years. Weight loss and the beneficial effects on comorbidities are equivalent among elderly and younger patients. SG should be offered to elderly patients who are deemed to be appropriate candidates.

KW - Bariatric surgery

KW - Elderly

KW - Morbid obese

KW - Sleeve gastrectomy

UR - http://www.scopus.com/inward/record.url?scp=84921059780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921059780&partnerID=8YFLogxK

U2 - 10.1007/s11695-014-1421-9

DO - 10.1007/s11695-014-1421-9

M3 - Article

C2 - 25223870

AN - SCOPUS:84921059780

VL - 25

SP - 222

EP - 228

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 2

ER -